dr waks on unmet needs in patients with her2 breast cancer
Published 3 months ago • 42 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
0:56
dr. yardley on unmet need for patients with her2 breast cancer
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
2:07
dr waks on ongoing research in residual her2 breast cancer
-
1:26
dr. hurvitz on unmet needs in her2 breast cancer
-
1:42
dr waks on anthracycline- vs taxane-based therapy in her2 breast cancer
-
1:11
unmet needs in the use of cdk4/6 inhibitors in early-stage hr /her2- breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
53:15
will new antibody drug conjugates cure bladder cancer?
-
2:53
unmet needs in the management of her2 mbc
-
0:34
helping to address unmet needs in metastatic hr /her2- breast cancer
-
2:32
dr waks on key questions regarding the first-line use of t-dxd in her2 breast cancer
-
5:28
unmet needs for metastatic breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
1:22
dr. borgen on successful progress in her2 breast cancer
-
1:11
dr. sparano discusses unmet needs in metastatic breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
1:20
dr. barrio on treatment options for her2 breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
3:12
the unmet needs in palliative care for breast cancer